I remain unconvinced on seeing new lows - IMO, fundamentally the company is massively undervalued even at today's SP, but I'll definitely be topping up again if it does happen. Markets are pretty irrational right now so I'm looking for opportunities.
News flow is tough for biotechs; mining companies can (and often do) drop an announcement every time they dig a hole, but biotech R&D and deals can take months if not years to get done. I do agree that some strong news flow will be important to support the SP between the consolidation and the dual listing.
Add to My Watchlist
What is My Watchlist?